Evidence map›Paper›PMID 33274194›Full record

ArticleBioMed research international2020

Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing

Dina Bugybayeva, Sholpan Ryskeldinova, Nadezhda Zinina, Makhpal Sarmykova, Nurika Assanzhanova, Zhailaubay Kydyrbayev, Kaissar Tabynov

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. The Role of Outer Membrane Protein 16 inVeterinary sciences · 2025
    Review
  4. Cell insight · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Registered Influenza Viral Vector BasedFrontiers in cellular and infection microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Dina BugybayevaResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0003-1891-2748
Sholpan RyskeldinovaResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0002-6538-8486
Nadezhda ZininaResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0003-3536-5483
Makhpal SarmykovaResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0002-0650-7457
Nurika AssanzhanovaResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0001-7267-3931
Zhailaubay KydyrbayevResearch Institute for Biological Safety Problems, 15 Momushuly, Gvardeyskiy 080409, Kazakhstan.ORCID https://orcid.org/0000-0001-9247-6273
Kaissar TabynovKazakh National Agrarian University, 8 Abay Avenue, Almaty 050010, Kazakhstan.ORCID https://orcid.org/0000-0001-5823-1280
Kazakh National Agrarian Research University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we first used recombinant influenza viral vector (rIVV) subtype H5N1 expressing from the open reading frame of NS1 80 and NS1 124 amino acids of

Indexed as

Drug CompoundingAnimalsBody WeightBrucella melitensisBrucella VaccineBrucellosisChlorocebus aethiopsGenetic VectorsGuinea PigsHumansImmunizationImmunization, SecondaryImmunodominant EpitopesInfluenza, HumanMiceProteinsBrucella VaccineImmunodominant EpitopesProteins

Identifiers

PMID33274194
PMCPMC7695499
OpenAlexW3101552013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.